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A B S T R A C T   
Human milk is a complex, dynamically changing biological fluid, which contains a large amount of non- 
conjugated carbohydrates, referred to as human milk oligosaccharides (HMOs). These HMOs are very impor-
tant for the infants as they play important roles in the formation of the gut microbiome, the immune system and 
support brain development. HMOs show highly complex structural diversity due to numerous linkage possibil-
ities of the building monosaccharides. In order to elucidate their structure–function relationship and to develop 
more effective infant formulas, cutting-edge analytical technologies are in great demand. In this paper, we review 
the current strategies for HMO analysis based on liquid phase separation methods. High performance liquid 
chromatography, capillary electrophoresis and their hyphenation with mass spectrometry are critically reviewed, 
emphasizing their advantages and disadvantages from practical point of views. Recent advances of the methods 
are categorized according to their application fields.   
1. Introduction 
Human milk is the main source of nutrition for newborns, but also 
contains a wide variety of bioactive components, among them a large 
number of unique oligosaccharides [1]. These human milk oligosac-
charides (HMOs) are the third most abundant ingredient in breast milk 
after lactose and lipids. Due to their indigestibility, HMOs are non- 
nutritive for infants, but contribute to multiple important biological 
effects. These unconjugated oligosaccharides reach the colon intact, 
where they act as prebiotics, stimulate the growth of beneficial bacteria; 
especially Bifidobacteria and thereby influence the composition of 
healthy intestinal microflora [2,3]. It is well known that the gut 
microbiota plays an important role in the development of the neonate 
immune system [4]. In addition, HMOs may modulate the immune 
function by altering host epithelial and immune cell responses and assist 
in the maintenance of balanced inflammatory responses [5,6]. Several 
studies revealed that HMOs provide protection against pathogens, such 
as Vibrio cholerae, Streptococcus pneumoniae, enteropathogenic Escherichia 
coli, Campylobacter jejuni or even HIV [7–9]. Furthermore, HMOs act as 
decoys, i.e., binding to pathogens to inhibit bacterial and viral adhesion 
to cell surface receptors and apparently protect breastfed infants against 
infections [10]. Besides their prebiotic, immunomodulatory and anti-
adhesive effects, HMOs may also influence the cognitive functions of 
newborns. Recent studies have shown that HMOs appear in the blood-
stream of the infant [11] and sialic acid residues play an important role 
in brain development and cell–cell interaction modulation [12] (see 
Table 1). 
HMOs are synthesized by glucosyltransferases in the mammary gland 
and built up from the following five monosaccharide monomers: D- 
glucose (Glc), D-galactose (Gal), N-acetylglucosamine (GlcNAc), L- 
fucose (Fuc) and sialic acid (in human, only N-acetylneuraminic acid 
(Neu5Ac)) (Fig. 1A). All HMOs carry lactose at their reducing end, which 
can be elongated by the addition of β1–3 or β1–6-linked lacto-N-biose 
(LNB) (Galβ1–3GlcNAc-, type 1 chain) or N-acetyllactosamine 
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(Galβ1–4GlcNAc-, type 2 chain) (Fig. 1B). Lactose or the elongated 
oligosaccharide chains can be fucosylated or sialylated via different 
linkages. As a matter of fact, HMOs have unusually high structural di-
versity because of the numerous linkage/anomericity options of the 
building monosaccharide units. The total concentration of these oligo-
saccharides in human milk ranges from approximately 20 mg/mL in 
colostrum to 5–15 mg/mL in mature milk [13]. Studies found that the 
level of HMOs and their composition vary among women and over the 
stage of lactation [13,14]. This diversity is influenced by many factors 
including geographical location and the genetic diversity within a 
population [6]. The greatest interpersonal variations have been 
observed in the fucosylation pattern, which depends on secretor and 
Lewis blood group statuses [15]. Reasons for individual variability 
include the frequency of breastfeeding, the lifestyle of the mother along 
Table 1 
Names, abbreviated names, monoisotopic masses and molecular structures of several important HMOs.  
Name Abbreviation Monoisotopic mass [Da] Molecular structure 
Lactose Lac 477.2 
Lacto-N-biose LNB 518.3 
N-acetyllactosamine LacNAc 518.3 
2-fucosyllactose 2′FL 651.3 
3-fucosyllactose 3FL 651.3 
Difucosyllactose DFL 825.4 
Lacto-N-triose LNT2 722.4 
3-sialyllactose 3′SL 838.4 
6-sialyllactose 6′SL 838.4 
Lacto-N-tetraose LNT 926.5 
Lacto-N-neotetraose LNnT 926.5 
Lacto-N-fucopentaose I LNFPI 1100.5 
Lacto-N-fucopentaose III LNFPIII 1100.5 
Sialyllacto-N-tetraose a LSTa 1287.6 
Sialyllacto-N-tetraose b LSTb 1287.6 
Sialyllacto-N-tetraose c LSTc 1287.6 
Disialyllacto-N-tetraose DSLNT 1648.8 
Para-lacto-N-neohexaose pLNnH 1375.7 
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with her weight and dietary habits, especially the level of protein intake. 
Thanks for the currently available high resolution analytical techniques, 
as of today more than 200 unique oligosaccharides [16] have been 
identified in human milk differing in size, charge and abundance. 
The structures of biomolecules determine their function, so various 
isomeric oligosaccharides can have to different biological effects, 
therefore, adequate identification of HMOs is essential. However, 
identifying and quantifying HMOs represent a major challenge due to 
the complexity of their structures. The most commonly used liquid phase 
separation methods for HMO analysis are liquid chromatography (LC) 
and capillary electrophoresis (CE). LC utilizes various stationary phases 
supporting reversed phase, anion exchange, porous graphitized carbon, 
and hydrophilic interaction modes. Capillary electrophoresis (CE) is 
another powerful analytical tool for HMO analysis in capillary zone 
(CZE) and capillary gel (CGE) electrophoresis modes. Both, LC or CE can 
be coupled to a mass spectrometer (MS) to obtain structural information. 
The purpose of this review is to summarize and describe the state-of-the- 
art liquid phase separation methods in the field of HMO analysis over the 
last five years and critically discuss their advantages and limitations. 
2. Advanced analytical methods for HMO analysis 
Investigation of human breastmilk started at the early 1900s [17] 
and since then various approaches have been developed for the HMO 
analysis. Elucidation of these oligosaccharide structures is highly 
important to reveal their biological function and thereby produce more 
suitable infant formulas. Although the analysis of glycan structures 
represents a separate field of science, i.e., part of glycomics, compre-
hensive analytical methods for the separation of oligosaccharides from 
human milk samples is still in progress. One reason for this is the great 
heterogeneity and complexity of their monosaccharide compositions 
and linkages. The low concentration of HMOs in the presence of the 
large lactose content further complicates their examination. In addition, 
oligosaccharides lack chromophores or fluorophores making their op-
tical detection difficult. 
2.1. Sample preparation techniques 
Before analysis, HMOs need to be isolated from the other compo-
nents present in breast milk, such as lipids, proteins and lactose [18–21]. 
The currently reported HMO sample preparation methods have similar 
steps, generally starting with the removal of fats and proteins. The 
defatting step is often performed simply by centrifugation or by solvent 
extraction. Protein precipitation is usually completed with organic sol-
vents, such as ethanol, chloroform/methanol, acetone or acetonitrile. In 
several studies membrane separation has been applied to eliminate milk 
proteins [21–24], because of the organic solvents, such as ethanol and 
acetonitrile result in lactose crystallization and oligosaccharides co- 
crystallization with lactose, which impairs HMO analysis [21]. Some 
potential interfering agents such as lactose, salts, derivatization and 
reduction agents may make the separation procedure more difficult. 
Several purification approaches like ion exchange chromatography, gel 
permeation chromatography, solid phase extraction (SPE) with porous 
graphitized carbon (PGC) or hydrophilic interaction liquid chromatog-
raphy (HILIC) sorbents have also been used to eliminate these agents, 
which made the process more complicated and time-consuming. 
Another issue is the possible loss of HMOs during the purification 
steps. In 2017, Wu et al. have developed a high-throughput 96-well plate 
based sample preparation protocol [25] allowing HMO profiling in large 
sample sets. However, separation of closely related structures and their 
quantification still calls for higher resolution separation techniques. 
2.2. High performance liquid chromatography for HMO analysis 
For quantitative characterization of oligosaccharides and their 
downstream structural elucidation, e.g., with by MS, it is crucial to 
choose the appropriate separation technique. The method must be 
suitable to separate many polar and branched isomeric structures. 
During the past years, a wide variety of HPLC methods have been 
developed and become frequently used for HMO analysis. HPLC can be 
used with label-free detection modes, such as refractive index, evapo-
rative light-scattering, charged aerosol, pulsed amperometric and MS 
detection. Unfortunately, without derivatization, HMOs cannot be 
detected with the most widely used optical detection methods due to 
their poor UV absorption and lack of fluorescent characteristics. How-
ever, a number of fluorescent or UV active labels are available, which 
increase detection sensitivity. The most frequently applied ones are 2- 
aminobenzamide (2-AB), 2-aminobenzoic acid (2-AA), 2-aminoacridone 
(2-AMAC), per-benzoylation and 1-phenyl-3-methyl-5-pyranozolone 
(PMP) [26]. 
There are a great number of stationary phases available for HMO 
separation by liquid chromatography. High-performance anion-ex-
change chromatography with pulsed amperometric detection (HPAEC- 
PAD) is one of the well-established techniques for the analysis of oli-
gosaccharides not requiring derivatization. This method is suitable for 
the separation of neutral or acidic HMOs, however, before the separa-
tion, pre-fractionation of the neutral and acidic oligosaccharides is 
required increasing the analysis time. It is important to note that the 
detection sensitivity of this approach is orders of magnitude less that of 
fluorescence or MS detection [27], thus in recent years, HPAEC-PAD 
became a less widely applied glycoanalytical tool. 
HILIC is another frequently used analytical tool in the field of HMO 
analysis. HILIC was originally developed to analyze polar and ionic 
species. In case of sugar analysis, 2-AB is the most frequently used la-
beling reagent. The method is well suited for the separation of longer 
positional and linkage isomers, including sialic acid isoforms [28]. On 
the other hand, HILIC works poorly for very similar small carbohydrates, 
such as trisaccharides [18]. 
The use of PGC stationary phases represent another LC option to 
separate oligosaccharides from human milk. PGC provides unique 
Fig. 1. (A) Monomer building blocks of the HMOs; (B) Elongation examples of with LNB or LacNAc with β1-3 or β1-6 linkages.  
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isomer separation, not only linkage isomers but also α/β anomeric 
forms. In cases when both anomers are present, it doubles the number of 
peaks and therefore complicates the evaluation of the resulting chro-
matograms. Borohydride reduction is a widely used method to alleviate 
this issue [18,25,29,30]. 
In recent years, infant formulas have been supplemented with 2′- 
fucosyllactose (2′FL) and lacto-N-neotetraose (LNnT) [31], thus quali-
tative and quantitative control of these ingredients are of high impor-
tance. Christensen et al. have been published a robust, easily applicable 
HPLC method with refractive index (RI) detection for the quantification 
of 2′FL and 3FL in different food samples, such as in infant formulas, 
cereal bars and milk-based products [32]. The separation was performed 
with HILIC column using isocratic elution with acetonitrile - water 
mobile phase containing triethylamine. The method was validated, 
highly robust and reproducible for the absolute quantification of 2′FL 
and 3FL in different food supplements by HPLC-RI as shown in Fig. 2. 
Similarly, Austin et al. developed two approaches for the analysis 
2′FL and LNnT oligosaccharides in infant formulas [33]. One method 
was based on HPAEC-PAD and the other on HILIC with fluorescence 
detection (FLD) after 2-AB labeling. Both methods worked well when 
used with spiked infant formulas. However, when the species were 
tested from production, the HPAEC-PAD method showed lower than 
expected abundance of 2′FL and LNnT. The authors hypothesized that 
the analytes and matrix components interacted during the infant for-
mula manufacturing process, apparently depending on the production 
conditions. 
In another study, ultrafiltration and centrifugation pretreatment 
methods were compared for 15 neutral and acidic HMOs for quantifi-
cation using UHPLC with FLD analysis of the products [24]. This simple 
sample preparation method only required dilution, centrifugation or 
ultrafiltration and the derivatization steps ensured high sensitivity. 
While in the ultrafiltration pretreatment step the recovery rate of dis-
ialyllacto-N-tetraose (DSLNT) was less than 50%, the centrifugation 
method provided good yield. 
The major drawback of LC based methods is the requirement of the 
use of oligosaccharide standards to determine retention time based 
structural elucidation with corresponding publicly available glycan li-
braries. However, the standards are frequently not available commer-
cially and if so they are very expensive or their purity is less adequate 
[33]. Therefore, in the future it will be necessary to produce good 
quality oligosaccharide standards due to the increasing need of using 
HMOs in infant formulas. Furthermore, the long chromatographic run 
times of typically 30–60 min is considered as a limitation. 
Fig. 2. HILIC-HPLC analysis of 2′FL and 3FL spiked sucrose and lactose standard in water (A), whole milk (B), UHT milk (C), yoghurt (D), infant formula (E) and 
cereal bars (F). Dotted lines are blank chromatograms for the corresponding matrices. nRIU: nano refractive index units. With permission from [32]. 
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2.3. Capillary electrophoresis for HMO analysis 
In addition to chromatographic based techniques, capillary electro-
phoresis is also broadly used as a powerful glycoanalytical tool, because 
of the low sample volume requirement, reduced buffer consumption, 
rapid and high resolution separations. CE offers several separation 
modes and the conditions can be easily altered during operation. For CE, 
derivatization of the mostly uncharged carbohydrates is necessary to 
ensure their proper electromigration. Applying a charged fluorescent 
label, such as 9-aminopyrene-1,3,6-trisulfonic acid (APTS), the sensi-
tivity of the method reaches the 10− 11–10− 12 M level [34]. In 2007, Bao 
et al. developed and validated a CE based method for the quantification 
of 12 major acidic HMOs using UV detection [35]. Later, this method 
was applied by others to test the concentration of 3-sialyllactose (3′SL), 
6-sialyllactose (6′SL) and DSLNT from cow, goat and equine milk [36] in 
search for potential sources of these oligosaccharides as infant formula 
additives. It was found that milk from monogastric animals contained 
more oligosaccharides than milk from ruminants, and mare milk may be 
a good source of infant formula oligosaccharides. 
Volpi and co-workers developed a CE method with simple UV 
detection at 254 nm to identify HMO standards and oligosaccharides 
from human milk samples [37]. They applied simple pretreatment steps 
and derivatization of oligosaccharides with 2-AMAC, an uncharged and 
hydrophobic fluorescent label. After derivatization, the labeled oligo-
saccharides were separated in borate buffer containing 20% methanol. 
This CE approach was capable to separate the main neutral and acidic 
oligosaccharides from breast milk in the presence of lactose and other 
high concentration impurities such as the excess fluorophores, proteins 
and salts. HMOs were tested from the four secretory groups Lewis- 
positive Secretors (Se +/Le + ), Lewis-positive non-Secretors (Se 
− /Le + ), Lewis-negative Secretors (Se+/Le− ), and Lewis-negative non- 
Secretors (Se − /Le− ). Comparing their results to HPAEC-PAD separa-
tions [38] and previous HPLC-ESI-MS characterization [27], this CE-UV 
approach provided high resolution and sensitivity for HMOs from these 
distinct genetic subgroups. It is important to note that the UV detection 
limit was significantly inferior to laser-induced fluorescence (LIF) and 
the long separation times limited the applicability of this method. 
Identification of unknown peaks in instances like this also require 
sequential exoglycosidase digestion [39] of MS based [40] analysis. 
Sarkozy et al. compared the electromigration properties of 10 major 
HMOs by multicapillary electrophoresis (12-capillary cartridge) in two 
separation matrices, the industry standard carbohydrate separation gel 
and borate-buffered dextran gel [34]. 2′FL, 3FL, lacto-N-tetraose (LNT) 
and lacto-N-neotetraose (LNnT) isomeric structures were present in the 
HMO test mixture. 2′FL and 3FL isomers were co-migrating in the 
standard carbohydrate separation gel matrix, while the LNT and LNnT 
isomers were co-migrating in borate-buffered dextran gel. Importantly, 
12 samples were simultaneously analyzed in less than 10 min and sep-
aration of all ten test mixture components were obtained by mixing the 
two separation gel buffer systems. They also quantified five low abun-
dant HMOs from human milk as shown in Fig. 3, proving that this system 
provided a means for rapid, sensitive and high-throughput HMO 
analysis. 
2.4. MS coupled to liquid phase HMO separation methods 
Mass spectrometry is frequently applied in the field of glycan anal-
ysis and also successfully used for milk oligosaccharide analysis for 
Fig. 3. Quantitative analysis of low concentration HMOs in a human milk sample. With permission from [34].  
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structural characterization. Electrospray ionization (ESI) and matrix- 
assisted laser desorption/ionization (MALDI) are the commonly used 
soft ionization modes for MS-based analysis of sugars. In MALDI ioni-
zation the sample is mixed or coated with an energy-absorbent matrix 
and ionized with a laser beam. This method generates single protonated 
ions from the analytes [41]. ESI, on the other hand, produces multiple- 
charged ions by utilizing electric field to convert solution-phase analytes 
into gas phase ions [42]. Permethylation is a commonly used technique 
to derivatize glycans for MS detection as it enhances and improves 
ionization and stabilizes the labile sialic acid moieties. Permethylation 
also help to prevent fucose rearrangement during MS analysis 
[40,43,44] and provides diagnostic fragment ions. MS coupled to 
chromatographic or electromigration separation methods makes struc-
tural identification of HMOs easier. Oursel et al. have described an LC- 
MS analysis of permethylated HMOs [45] comparing the analytical 
strategies with RPLC and PGC. Native HMOs were separated on a PGC 
column and permethylated species on an RPLC column, both were 
detected by an iontrap MS instrument. They concluded that the use of 
PGC column worked better for high-throughput detection of species, due 
to the faster sample preparation, while analysis of permethylated HMOs 
by RPLC-MS/MS was more suitable for structural characterization. 
Utilization of biosynthetic routes to generate HMOs are not yet 
completely solved, but comprehensive bioanalytical methods can bring 
us closer to accomplish this endeavor. HMOs have a core structure 
carrying lactose at the reducing end, which can be connected to lacto-N- 
biose (LNB) in type 1 chain structure. In contrast, type 2 chain structure 
can be elongated by the addition of N-acetyllactosamine (LacNAc) 
moieties as shown in Fig. 1/B. LNB causes chain termination, while 
additional LNB or LacNAc moieties may be attached to LacNAc. Humans 
have higher amount of type 1 oligosaccharides than that of type 2. The 
Fig. 4. Base peak HILIC-MS analysis of free oligosaccharides in human milk using positive detection mode. (A) Neutral oligosaccharides. (B) Acidic oligosaccharides. 
With permission from [47]. 
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predominance of type 1 oligosaccharides can be considered specific to 
humans, milk from other mammals contains mainly type 2 oligosac-
charides [46]. Surprisingly, Balogh et al. concluded that non-conjugated 
LacNAc was present in a much higher concentration than non- 
conjugated LNB in human milk [18], just the opposite of the human 
type 1 and type 2 chain ratio. A PGC stationary phase based LC-MS/MS 
method was developed to identify and quantify these two important free 
disaccharides LNB and LacNAc from human milk. The method was used 
to track the concentration changes of these two HMO building block 
disaccharides throughout the first week of lactation and found them 
continuously decreasing during this period. Understanding the ratio of 
free LNB and free LacNAc in human milk contributed to the exploration 
of HMO biosynthesis. 
Structural assignment of isomeric oligosaccharides in HMO analysis 
is one of the most challenging tasks. PGC stationary phase has been 
proven as a robust technique for the analysis of isomeric HMOs with LC- 
MS. In a Brazilian study, Tonon et al. quantified the 16 most abundant 
HMOs by LC-MS/MS method using a PGC column [21]. With a quick and 
simple sample preparation method, the neutral and acidic HMOs were 
simultaneously examined in a single run with the isomeric pair of LNT 
and LNnT well separated. The drawback of this study was the long 
chromatographic run time. 
A UPLC-MS/MS method was developed with multi reaction moni-
toring (MRM) mode to separate 4 pairs of isomeric HMO structures (2′FL 
and 3FL; 3′SL and 6′SL; LNFPI and LNFPIII; LSTa as well as LSTb and 
LSTc) from a 12 oligosaccharide containing standard mixture [20]. 
Significant correlations were found between some HMO species from 61 
mothers, suggesting that these HMOs may had common synthesis pre-
cursors. However, no separation of the abundant and important HMOs 
in human milk, LNT and LNnT core isomer pair was obtained in this 
study. 
The above-mentioned studies mainly focused on the most frequent, 
low molecular weight oligosaccharides and only reported a limited 
number of HMOs. In a very recent and emerging work Stein and co-
workers created a searchable reference MS library of annotated HMOs 
[47]. They characterized reference standards by HILIC-ESI-MS/MS and 
the library currently contains 469 positive and negative ion spectra, an 
example is shown in Fig. 4. The reference standard mixture contained 
human milk from 100 breastfeeding mothers and the library 
accommodated identification of unknown reduced or non-reduced oli-
gosaccharides from human milk. When standards are not available, this 
information represents a promising option for future work. However, in 
this study high molecular weight oligosaccharides (>10 sugar units) 
have not been completely characterized so far. 
In another interesting study, 100 different permethylated high mo-
lecular weight HMOs were identified by nano LC-MS/MS using RPLC by 
the Azadi group [19]. Previous studies usually focused on identification 
of HMOs in the lower molecular weight region, because higher molec-
ular weight increased the complexity of structures, thus, complicated 
the analysis as shown in Fig. 5, but permethylation helped isomer 
analysis, due to partially methylated products. This approach may 
provide a high-throughput option in the future, may also be suitable for 
screening breast milk samples or commercial products. 
CE-ESI-MS is another emerging tool in glycomics studies [39,48,49]. 
For negatively charged carbohydrates or sugars labeled with APTS, the 
CE system has to be coupled with negative ESI detection. In this mode 
the detection highly selective but less sensitive and more prone to 
corona discharge effects than in positive ESI mode. To alleviate the 
issue, a CE-ESI-CID-MS/MS method was developed utilizing multiple 
carbonyl-reactive target mass tag (TMT) labeled HMO standards [50]. 
Aminoxy TMT-label gave glycans are positively charged in acidic 
buffers, thus, allowed the use of positive ESI mode with enhanced 
sensitivity. In this study the authors separated aminoxy TMT-labeled 
isomeric HMO standards with increased resolution of the isomeric 
structures using traveling wave ion mobility as a second separation 
dimension. 
3. Conclusion and future prospective 
Continuously growing evidence shows the beneficial effects of HMOs 
on breast-fed infants by shaping the intestinal flora, modulating their 
immune responses and protecting them from infections and other dis-
eases. These favorable effects are dependent on the structures of the 
HMOs, making their comprehensive characterization important for 
better understanding of the phenomena. However, analysis of HMOs is 
highly challenging because of their heterogeneity and diverse isomeric/ 
anomeric structures. The lack of easily ionisable or chromophore/fluo-
rophore groups on oligosaccharides further complicates the analysis. 
Fig. 5. Increasing molecular weight proportionally increases the structural complexity of glycoforms. With permission form [19].  
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Over the past decades, multiple analytical approaches have been 
developed for HMO analysis, most of them were based on liquid phase 
separation methods. In most instances, potential interfering agents had 
to be removed from the milk prior to analysis, making sample prepa-
ration an important first step. Proper sample preparation also improves 
the resolution of the resulting separation, but makes the process more 
time-consuming with the risk of losing low concentration sugars. 
Oligosaccharide additives to infant formulas have to be controlled by 
well-established, reliable and rapid analytical techniques. While in early 
days mostly HILIC methods were developed to measure ingredients in 
milk formulas, CE has been rapidly catching up in the field of identifi-
cation of milk oligosaccharides. One of the other major challenges of 
liquid phase separation-based methods is the need for standard refer-
ence libraries, to be utilized for retention/migration time based struc-
tural elucidation. The availability of such standards is very limited and 
often contain impurities. MS coupled to LC or CE proved to be an effi-
cient approach to further elucidate HMO structures, but require proper 
glycoinformatics toolsets. While the recently introduced analytical 
strategies discussed in this review may shed light on the biomedical 
impact of oligosaccharides and contribute to the improvement of food 
supplements, further development in the field is necessary to obtain the 
higher selectivity and sensitivity to gain deeper understanding of the 
biological relevance of HMOs. 
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